BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22432757)

  • 1. HLA tissue typing has no effect on the outcome of patients undergoing a living-donor liver transplant: a single-center experience in Egypt.
    Yosry A; Said M; Esmat G; Al-Serafy M; Omar A; Doss W; Omran D; Saad Y; Kamel S; Abdel-Bary A; Hatata Y; Hosny A
    Exp Clin Transplant; 2012 Apr; 10(2):136-40. PubMed ID: 22432757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
    Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation.
    Ali MA; Elshobari MM; Salah T; Kandeel AR; Sultan AM; Elghawalby AN; Shehta A; Elsayed U; Fathy O; Yassen A; Wahab MA
    Liver Transpl; 2017 Jan; 23(1):43-49. PubMed ID: 27516392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
    Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
    Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Transplant Outcomes in a Newly Started Program.
    Sultanaliev T; Zhexembayev A; Mukazhanov A; Zharkymbekov B; Kuttymuratov G; Spatayev Z; Ibrayev B; Yesmembetov K; Ashimkhanova A; Asykbayev M
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():120-2. PubMed ID: 26640930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
    Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
    Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.
    Yankol Y; Mecit N; Kanmaz T; Cimsit B; Cakaloglu Y; Acarli K; Kalayoglu M
    Exp Clin Transplant; 2016 Apr; 14(2):191-200. PubMed ID: 26030810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study.
    Denewar AA; Monem El-Hendy YA; Wafa EW; Ghorab AA; Sheashaa HA; Rashad RH; Nagib AM; Neamatallah AH; Abbas MH; Shokeir AA
    Exp Clin Transplant; 2015 Oct; 13(5):402-7. PubMed ID: 26450463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.
    Goldaracena N; Barbas AS; Galante A; Sapisochin G; Al-Adra D; Selzner N; Galvin Z; Cattral MS; Greig PD; Lilly L; Bhat M; McGilvray ID; Ghanekar A; Levy G; Grant DR; Selzner M
    Clin Transplant; 2018 Aug; 32(8):e13304. PubMed ID: 29947154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age.
    Chapman WC; Vachharajani N; Collins KM; Garonzik-Wang J; Park Y; Wellen JR; Lin Y; Shenoy S; Lowell JA; Doyle MB
    J Am Coll Surg; 2015 Jul; 221(1):59-69. PubMed ID: 25872684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-Year Recipient Morbidity of Liver Transplantation Using Pure Laparoscopic Versus Open Living Donor Right Hepatectomy: Propensity Score Analysis.
    Park J; Kwon CHD; Choi GS; Lee SK; Kim JM; Oh J; Chung YJ; Kim KS; Lee JS; Lee KW; Kim GS; Gwak MS; Ko JS; Kwon JH; Kim K; Lee SH; Joh JW
    Liver Transpl; 2019 Nov; 25(11):1642-1650. PubMed ID: 31271699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB; Hothersall E; Preston J; Brown AM; Hawley CM; Wall D; Griffin AD; Isbel NM; Nicol DL; Johnson DW
    Transplantation; 2003 Nov; 76(10):1452-7. PubMed ID: 14657685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant.
    DiNorcia J; Lee MK; Harlander-Locke MP; Xia V; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW; Agopian VG
    JAMA Surg; 2015 Nov; 150(11):1066-72. PubMed ID: 26308380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retransplant as Rescue Treatment for ABO-Compatible Living-Donor Liver Transplant Related Antibody-Mediated Rejection: A Case Report.
    Ho MH; Wu SY; Ou KW; Su TF; Hsieh CB
    Exp Clin Transplant; 2018 Apr; 16(2):222-226. PubMed ID: 26742858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Hepatis C Virus-Related Immunologic Markers and Their Impact on Outcomes of Living-Donor Kidney Transplant Recipients.
    Denewar AA; Abbas MH; Sheashaa HA; Abdelaal I; El-Dahshan K; Matter YE; Refaie AF
    Exp Clin Transplant; 2019 Feb; 17(1):79-83. PubMed ID: 29957163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical site infection and risk factors following right lobe living donor liver transplantation in adults: A single-center prospective cohort study.
    Aktas A; Kayaalp C; Gunes O; Gokler C; Uylas U; Cicek E; Ersoy Y; Kose A; Bayindir Y; Aydin C; Yilmaz S
    Transpl Infect Dis; 2019 Dec; 21(6):e13176. PubMed ID: 31539456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Donor Recipient Gender and Race Mismatch on Graft Outcomes in Patients With End-Stage Liver Disease Undergoing Liver Transplantation.
    Zhang Y
    Prog Transplant; 2017 Mar; 27(1):39-47. PubMed ID: 27895103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.